Abcellera Biologics Inc ABCL

$12.68 +0.31 (2.51%)

Valuation

Market cap
3,792,778,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
5,758,400
Avg volume
7,199,298
Day's range
$11.69 – $12.86
Shares out
306,611,000
Stochastic %K
35%
Beta
1.41
Analysts
Strong Sell
Price target
$16.82

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

Rastafari Oct 16, 12:18 AM
$ABCL We are in a hot space! https://www.reuters.com/legal/litigation/vir-gilead-team-up-solid-tumor-cancer-therapies-up-19-billion-deal-2026-10-14/
1 replies
CoffeeRocks Oct 15, 8:39 PM
$LPCN $BCTX $SLS $ABCL $VKTX LPCN needs a little……
1 replies
MarketMaestro4747 Oct 15, 8:17 PM
$ABCL friendly dip
0 replies
Stocktradesmoon Oct 15, 6:46 PM
$ABCL POWER HOUR Up Next‼️ News after hours ahead of our Major Catalyst Event in a few days?!!! Carl CEO loves to burn 🔥 those SHORTS!!
0 replies
Stocktradesmoon Oct 15, 6:36 PM
$ABCL Get in NOW!!! You DON’T want to MISS OUT on News 🗞️ and Major Catalyst Event in a few days!!! We Moved 200-300% on Phase II Result with News Coming on the 12 Week DATA 📊 we are going to sky rocket 🚀 $18-$23!!!
1 replies
Stocktradesmoon Oct 15, 6:29 PM
$ABCL
0 replies
Stocktradesmoon Oct 15, 6:25 PM
$ABCL ABcellera 🔥!!!
0 replies
Stocktradesmoon Oct 15, 6:22 PM
$ABCL Power Hour Coming up!!! $13’sss! News 🗞️ after hours 🔥!!!
0 replies